Literature DB >> 12152838

Clinical spectrum of drug rashes due to antiepileptics.

V K Sharma1, M Vatve, I M Sawhney, B Kumar.   

Abstract

Clinical profile of 105 patients with cutaneous drug eruption due to antiepileptic drugs was studied between 1992-1996. Maculopapular rash was the most common presentation though significant number of patients (29.5%) had serious rashes like Stevens Johnson syndrome (SJS) and toxic epidermal necrosis (TEN). Phenytoin and carbamazepine were the two commonly implicated drugs. Significant number of our patients had liver and kidney involvement (47.34 and 21.04%, respectively). The overall prevalence of drug rash with antiepileptics in a review of 240 cases was found to be 2.5%. Patch testing with antiepileptic drugs done in 20 patients gave 60% positive results with the suspected drug. Thus patch test is a useful tool in confirming the diagnosis of drug rashes and warrants further studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 12152838

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  6 in total

1.  The use of three-dimensional similarity in assessing the risk of cross-reactivity between carbamazepine and psychotropic drugs.

Authors:  Eric Le Louarn; Annick Barbaud; Philippe Trechot; Gilles Marcou; Jean-Pierre Lepoittevin
Journal:  Eur J Clin Pharmacol       Date:  2014-01-10       Impact factor: 2.953

2.  Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

Authors:  P Brent Ferrell; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

3.  Can vitamin B-complex aggravate the carbamazepine induced toxic epidermal necrolysis?

Authors:  Mayuresh V Fegade; Sushama A Bhounsule; Ian Pereira
Journal:  J Clin Diagn Res       Date:  2012-11

4.  Multifocal Bullous Fixed Drug Erruption Due To Phenytoin: A Lesson Learned!

Authors:  Ankur Jain; Naresh Gupta
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 5.  In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 6.  Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.